ArticleDiscover oncology2026
Genetic evidence supporting obesity as a risk factor for lung squamous cell carcinoma and the identification of MFAP1 as a shared genetic target.
Article in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundObservational studies have suggested that obesity may protect against lung cancer, particularly lung squamous cell carcinoma (LUSC). However, these findings are likely influenced by confounding factors such as smoking. We aimed to clarify the genetic relationship between body mass index (BMI) and LUSC and to identify potential shared therapeutic targets.
methodsWe combined several genome-wide approaches to investigate shared genetic architecture between BMI and LUSC, including genetic correlation analyses and bidirectional Mendelian randomization (MR). We then examined tissue- and cell-level heritability enrichment and used gene-level integrative analyses to prioritize functional candidates. Finally, phenome-wide MR was applied to explore potential clinical consequences of targeting key genes.
resultsBMI and LUSC showed a significant positive genetic correlation. MR analyses provided genetic evidence consistent with acausal effect of higher BMI on increased LUSC risk. Genetic signals were enriched in selected tissues and cell types, including epithelial and neuronal populations. Genetic signals were enriched in selected tissues and cell types, including epithelial and neuronal populations. Across SMR and colocalization analyses, MFAP1 emerged as a shared functional gene linking BMI and LUSC. Phenome-wide MR identified limited but notable associations between higher MFAP1 levels and connective tissue–related and other clinical phenotypes, suggesting that potential on-target effects would need to be considered carefully.
conclusionsThis study supports obesity as a genetic risk factor for LUSC and highlights MFAP1 as a potential shared target at the interface of adiposity and squamous lung carcinogenesis. These findings provide a genetic framework for understanding obesity-related LUSC risk and offer hypotheses for future mechanistic and translational research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.